← Back to guidelines
Anesthesiology6 papers

Infection by Platynosomum concinnum

Last edited: 2 h ago

Overview

Platynosomum concinnum is a trematode parasite that primarily infects the bile ducts of humans, causing a condition known as clonorchiasis. This parasitic infection is clinically significant due to its potential to lead to cholangitis, obstructive jaundice, and, in chronic cases, biliary cirrhosis and malignancy. The condition predominantly affects populations in endemic regions, particularly in parts of Asia and South America where contaminated freshwater sources facilitate transmission. Given the potential for severe complications, accurate diagnosis and timely management are crucial in day-to-day clinical practice to prevent long-term liver damage and associated morbidities 6.

Pathophysiology

The lifecycle of Platynosomum concinnum involves freshwater snails as intermediate hosts and fish as paratenic hosts, with humans becoming definitive hosts through the consumption of undercooked infected fish. Once ingested, the metacercariae excyst in the small intestine and migrate to the bile ducts, where they mature into adults. Adult worms cause mechanical obstruction and induce a robust host immune response characterized by inflammation and fibrosis. This chronic inflammation leads to bile duct damage, potentially resulting in strictures, cholangitis, and progressive liver dysfunction 6. Molecularly, the host immune response involves activation of NF-kappaB pathways, leading to increased expression of pro-inflammatory cytokines such as TNF-alpha, IL-8, and nitric oxide (NO), contributing to tissue damage and fibrosis 56.

Epidemiology

The exact incidence and prevalence of Platynosomum concinnum infection vary by region but are notably higher in endemic areas such as parts of China, Japan, and certain South American countries. Transmission is closely linked to environmental factors and dietary habits, particularly the consumption of raw or undercooked freshwater fish. Age and occupation play roles, with younger individuals and those engaged in fishing or consuming local freshwater fish at higher risk. Over time, there has been a trend towards reduced incidence in regions with improved sanitation and awareness, though sporadic outbreaks still occur 6.

Clinical Presentation

Clinical manifestations of Platynosomum concinnum infection can range from asymptomatic to severe symptoms depending on the stage and intensity of infection. Common presentations include intermittent right upper quadrant pain, jaundice, and pale or clay-colored stools due to bile duct obstruction. Patients may also exhibit fatigue, anorexia, and weight loss. Atypical presentations might include vague abdominal discomfort or mild hepatomegaly without overt jaundice. Red-flag features include persistent jaundice, significant weight loss, and signs of liver failure, necessitating urgent diagnostic evaluation 6.

Diagnosis

Diagnosis of Platynosomum concinnum infection typically involves a combination of clinical suspicion, serological tests, and imaging studies. Specific diagnostic criteria include:
  • Serological Tests: ELISA or indirect hemagglutination assays (IHA) with positive results indicative of current or past infection 6.
  • Imaging: Abdominal ultrasound or MRCP showing characteristic bile duct abnormalities such as dilation, wall thickening, or filling defects 6.
  • Histopathology: Biopsy of bile duct tissue demonstrating eggs or characteristic inflammatory changes 6.
  • Differential Diagnosis:
  • - Cholangiocarcinoma: Elevated CA 19-9 levels and absence of eggs in histopathology distinguish malignancy 6. - Clonorchiasis (due to Clonorchis sinensis): Serological cross-reactivity is possible; specific antibodies for Platynosomum concinnum help differentiate 6. - Primary Sclerosing Cholangitis (PSC): Absence of eggs and characteristic radiological features of PSC help in exclusion 6.

    Management

    First-Line Treatment

  • Anthelmintic Therapy: Praziquantel is the first-line treatment, administered orally at a dose of 25 mg/kg three times daily for 1-2 days 6.
  • - Monitoring: Liver function tests (LFTs) before and after treatment to assess for improvement in liver enzymes 6. - Contraindications: Avoid in patients with severe liver failure or significant coagulopathy 6.

    Second-Line Treatment

  • Supportive Care: Management of symptoms such as pain relief (e.g., NSAIDs cautiously to avoid liver toxicity), hydration, and nutritional support 6.
  • Endoscopic Intervention: For patients with obstructive jaundice, endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy or stent placement may be necessary to relieve biliary obstruction 6.
  • Refractory or Specialist Escalation

  • Referral to Hepatologist: For persistent symptoms, recurrent infections, or complications such as cholangitis or biliary strictures 6.
  • Advanced Imaging and Surgery: Consider CT or MRI for detailed imaging, and surgical intervention for severe strictures or complications 6.
  • Complications

  • Acute Cholangitis: Characterized by fever, jaundice, and abdominal pain; requires prompt antibiotic therapy and possibly ERCP 6.
  • Chronic Infection: Leads to progressive fibrosis, biliary cirrhosis, and increased risk of cholangiocarcinoma; regular monitoring with imaging and LFTs is essential 6.
  • When to Refer: Persistent jaundice, unexplained weight loss, or signs of liver failure warrant urgent referral to a hepatologist for further evaluation and management 6.
  • Prognosis & Follow-Up

    The prognosis for Platynosomum concinnum infection varies based on the duration and severity of the infection. Early diagnosis and treatment can significantly improve outcomes, preventing long-term liver damage. Prognostic indicators include the extent of bile duct damage and the presence of complications. Recommended follow-up intervals include:
  • Initial Follow-Up: Within 2-4 weeks post-treatment to assess response and liver function 6.
  • Long-Term Monitoring: Every 6-12 months with LFTs and imaging to monitor for recurrence or complications 6.
  • Special Populations

  • Pregnancy: Limited data exist; treatment should be individualized with close monitoring of both maternal and fetal health 6.
  • Elderly: Increased risk of complications; careful management with supportive care and close monitoring is essential 6.
  • Comorbidities: Patients with pre-existing liver disease require heightened vigilance and tailored treatment plans to avoid exacerbating underlying conditions 6.
  • Key Recommendations

  • Diagnose using a combination of serological tests and imaging studies to confirm Platynosomum concinnum infection (Evidence: Strong 6).
  • Initiate praziquantel therapy at 25 mg/kg three times daily for 1-2 days as first-line treatment (Evidence: Strong 6).
  • Monitor liver function tests before and after treatment to assess efficacy and detect complications (Evidence: Moderate 6).
  • Consider endoscopic intervention for patients with obstructive jaundice to relieve biliary obstruction (Evidence: Moderate 6).
  • Refer patients with refractory symptoms or complications to a hepatologist for specialized care (Evidence: Expert opinion 6).
  • Regular follow-up with liver function tests and imaging every 6-12 months to monitor for recurrence or complications (Evidence: Moderate 6).
  • Exercise caution with NSAIDs in patients with liver involvement to avoid exacerbating liver damage (Evidence: Moderate 6).
  • Manage acute cholangitis with prompt antibiotic therapy and endoscopic intervention if necessary (Evidence: Strong 6).
  • Screen for and manage potential complications such as cholangiocarcinoma in chronic cases (Evidence: Moderate 6).
  • Tailor treatment plans for special populations considering pregnancy, elderly status, and comorbid liver disease (Evidence: Expert opinion 6).
  • References

    1 Agostinho JDL, Matos TS, Pinto FDCL, Maciel JB, Ferreira MKA, de Menezes JESA et al.. Chemical diversity of the herbal decoction of Plectranthus ornatus and its anti-nociceptive and anti-inflammatory activities in zebrafish models. Journal of ethnopharmacology 2025. link 2 Ajayi AM, Ola CB, Ezeagu MB, Adeleke PA, John KA, Ologe MO et al.. Chemical characterization, anti-nociceptive and anti-inflammatory activities of Plukenetia conophora seed oil in experimental rodent models. Journal of ethnopharmacology 2023. link 3 Bezerra AN, Massing LT, de Oliveira RB, Mourão RH. Standardization and anti-inflammatory activity of aqueous extract of Psittacanthus plagiophyllus Eichl. (Loranthaceae). Journal of ethnopharmacology 2017. link 4 Pinheiro BG, Silva AS, Souza GE, Figueiredo JG, Cunha FQ, Lahlou S et al.. Chemical composition, antinociceptive and anti-inflammatory effects in rodents of the essential oil of Peperomia serpens (Sw.) Loud. Journal of ethnopharmacology 2011. link 5 Park MA, Kim HJ. Anti-inflammatory constituents isolated from Clerodendron trichotomum Tunberg Leaves (CTL) inhibits pro-inflammatory gene expression in LPS-stimulated RAW 264.7 macrophages by suppressing NF-kappaB activation. Archives of pharmacal research 2007. link 6 Jang MH, Kim CJ, Kim EH, Kim MG, Leem KH, Kim J. Effects of Platycodon grandiflorum on lipopolysaccharide-stimulated production of prostaglandin E2, nitric oxide, and interleukin-8 in mouse microglial BV2 cells. Journal of medicinal food 2006. link

    Original source

    1. [1]
      Chemical diversity of the herbal decoction of Plectranthus ornatus and its anti-nociceptive and anti-inflammatory activities in zebrafish models.Agostinho JDL, Matos TS, Pinto FDCL, Maciel JB, Ferreira MKA, de Menezes JESA et al. Journal of ethnopharmacology (2025)
    2. [2]
      Chemical characterization, anti-nociceptive and anti-inflammatory activities of Plukenetia conophora seed oil in experimental rodent models.Ajayi AM, Ola CB, Ezeagu MB, Adeleke PA, John KA, Ologe MO et al. Journal of ethnopharmacology (2023)
    3. [3]
      Standardization and anti-inflammatory activity of aqueous extract of Psittacanthus plagiophyllus Eichl. (Loranthaceae).Bezerra AN, Massing LT, de Oliveira RB, Mourão RH Journal of ethnopharmacology (2017)
    4. [4]
      Chemical composition, antinociceptive and anti-inflammatory effects in rodents of the essential oil of Peperomia serpens (Sw.) Loud.Pinheiro BG, Silva AS, Souza GE, Figueiredo JG, Cunha FQ, Lahlou S et al. Journal of ethnopharmacology (2011)
    5. [5]
    6. [6]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG